Evaluation of the Effectiveness of a Day Patient-caregiver Psychoeducationnal Program on the Burden of Caregivers

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Bipolar disorder (BD) has a huge impact on the lives of patient and their relatives. Psychoeducation programs on BD has been shown to be effective on the burden of patients and their caregivers. However, actual programs appear to be incompatible with patients obligations and services requirements of the service. The development of minute programs (in one day) is justified.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Be over 18 years old;

• Meet the criteria for bipolar disorder (I, II, unspecified) according to the DSM-5 criteria;

• Be able to understand the nature, purpose and methodology of the study;

• Presence of a caregiver

• Subject over 18 years old;

• Subject designated as a regular caregiver of a patient with bipolar disorder. A regular caregiver is a trusted person designated by the patient as being one of his main support, having knowledge of the diagnosis of bipolar disorder and who can be called upon in the context of care.

• Subject able to understand the nature, purpose and methodology of the study;

Locations
Other Locations
France
University Hospital of Montpellier
RECRUITING
Montpellier
Contact Information
Primary
Kathlyne DUPUIS MAURIN
k-dupuis@chu-montpellier.fr
+33467335663
Backup
Maude SENEQUE
m-senequehaize@chu-montpellier.fr
+33467335663
Time Frame
Start Date: 2022-11-09
Estimated Completion Date: 2025-11-30
Participants
Target number of participants: 240
Treatments
Experimental: Bp OneDay programm
The BP One-Day program is based on a single day of psychoeducation .
No_intervention: Waiting List
Patients assigned in control group will be placed in waiting list and will benefit from the program after their participation to this study. During study participation, they will receive treatment as usual.
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Montpellier

This content was sourced from clinicaltrials.gov